Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Banka BioLooNSE:BANKA +2.73%77 ROE % is 16.22% as of Mar. 2026, which is 93% above its 10-year median of 8.40. GuruFocus rates NSE:BANKA with a GF Score™ of 77/100 and a GF Value™ of ₹87.15 (Fairly Valued). The stock has 5 warning signs investors should review. Among 3,004 Industrial Products companies, Banka BioLoo ranks worse than 71.64% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Banka BioLoo's annualized net income for the quarter that ended in Mar. 2026 was ₹64.2 Mil. Banka BioLoo's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₹395.6 Mil. Therefore, Banka BioLoo's annualized ROE % for the quarter that ended in Mar. 2026 was 16.22%.
The historical rank and industry rank for Banka BioLoo's ROE % or its related term are showing as below:
NSE:BANKA'
s ROE % Range Over the Past 10 Years
Min: -25.01 Med: 8.4 Max: 30.72
Current: 1.11
During the past 13 years, Banka BioLoo's highest ROE % was 30.72%. The lowest was -25.01%. And the median was 8.40%.
NSE:BANKA's ROE % is ranked worse than 71.64% of 3004
companies
in the Industrial Products industry
Industry Median: 5.92
vs NSE:BANKA: 1.11
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Banka BioLoo ROE % Related Terms
Banka BioLoo ROE % Historical Data
* Premium members only.
The historical data trend for Banka BioLoo's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pollution & Treatment Controls subindustry, Banka BioLoo's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Banka BioLoo ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Banka BioLoo's ROE % distribution charts can be found below:
* The bar in red indicates where Banka BioLoo's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Banka BioLoo (NSE:BANKA) has a ROE % of 16.22% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Banka BioLoo and its competitors. This is 93% above median its historical median of 8.40. According to the industry distribution chart, Banka BioLoo ranks #2152 out of 3004 companies in the Industrial Products industry, placing it in the top 71.6%.
Is Banka BioLoo's ROE % too high?
Banka BioLoo's current ROE % of 16.22% is 93% above median its 10-year median of 8.40. The Industrial Products industry median ROE % is 5.92. Banka BioLoo's value of 16.22% is 174% above this industry median. Based on the distribution chart, Banka BioLoo ranks #2152 out of 3004 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Banka BioLoo has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Banka BioLoo's ROE % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Banka BioLoo ranks #2152 out of 3004 companies for ROE %. This places Banka BioLoo in the lower half of its industry. The industry median ROE % is 5.92. Banka BioLoo's value of 16.22% is 174% above this benchmark. While the company's 10-year median is 8.40 vs. the industry median of 5.92, Banka BioLoo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.92, based on 3,004 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Banka BioLoo's current ROE % of 16.22% is 174% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Banka BioLoo and its competitors. For the Industrial Products industry, the median ROE % is 5.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Banka BioLoo's current ROE % is 16.22%, which is 93% above median its own 10-year median of 8.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Banka BioLoo stock overvalued right now?
Based on GuruFocus' analysis, Banka BioLoo (NSE:BANKA) is currently considered Fairly Valued. The stock's GF Value™ is ₹87.15, compared to a current price of ₹90.32 — trading 3.6% above its estimated fair value. The current ROE % is 16.22%, which is 93% above median its 10-year median of 8.40 and 174% above the Industrial Products industry median of 5.92. Banka BioLoo's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Banka BioLoo (NSE:BANKA), the current ROE % is 16.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Banka BioLoo (NSE:BANKA) Overvalued in 2026?
Based on GuruFocus' analysis, Banka BioLoo stock appears to be overvalued.
The current stock price of ₹90.32 is trading 3.6% above its estimated GF Value™ of ₹87.15.
GuruFocus considers Banka BioLoo to be Fairly Valued.
Key valuation signals for NSE:BANKA:
ROE %: 16.22% (93% above median its 10-year median of 8.40)
GF Value™: ₹87.15 vs. price of ₹90.32 (3.6% above fair value)
Industry Position: 174% above the Industrial Products median (#2152 of 3004)
No single metric tells the full story. See the NSE:BANKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Banka BioLoo Ltd provides sanitation infrastructures and human waste management solutions and services. It is engaged in the business of manufacturing, supplying, and installing Bio toilets, setting up Fecal Sludge Treatment Plants (FSTPs), waste water treatment plants, Effluent treatment plants, and their operation and maintenance. The company has only one reportable business segment, which is the manufacturing, supplying, and installation of Bio toilets and related AMOC services. It provides services to various schools, villages, resorts, indian railways, small communities, industrial factories, construction sites, and others. Geographically, the company operates only in India.
77GF Score
Get the complete analysis for NSE:BANKA
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BANKA has been successfully added to your 
